Investigation of Activation of Latissimus Dorsi Muscle Segments During Functional Reach Activity in Chronic Stroke Patients

April 13, 2022 updated by: Tuba Kaya Benli, Hacettepe University

Latissimus Dorsi (LD); Medial sacrum, lumbar vertebrae and lower thoracic vertebrae 10-12 lateral to the spinous processus. It is a fan-like wide muscle that connects to the inferior angle of the scapula and ribs, adheres to the anterior surface of the proximal humerus and continues with aponeurosis of the contralateral Gluteus Maximus below. The activation of the LD muscle during the functional reach activity, which we use most frequently in daily living activities, affects the upper extremity and trunk movements. Therefore it is important muscle that affects the quality of movement.

The study include individuals with stroke that diagnosed by the neurologist and include healthy subjects. During sitting activity, they will be required to reach three different distances in the sagittal and scapular plane: arm length, 125% of the arm length and end point where it can reach the modified functional reach test. During the activity, electromyography (EMG) activation of latissimus dorsi, anterior deltoid and erector spina muscles will be examined with electromyographic device.

Hypothesis originating from the investigation:

H1: Latissimus dorsi muscle segments show different activation during functional reach activity.

H2: Activation of latissimus dorsi muscle segments is affected by reaching direction during functional reach activity.

H3: Activation of latissimus dorsi muscle segments is affected by reaching distance during functional reach activity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Measurements will be made during the sitting activity of the individuals included in the study. Individuals will be asked to reach midsternal height cups in two separate planes, sagittal and scapular, at arm's end, 125% of arm's distance and end point where it can reach according to modified functional reach test.

Muscle activation of latissimus dorsi, erector spina and anterior deltoid muscles will be measured by superficial electromyographic measurement. Muscle activation according to SENIAM for erector spina and anterior deltoid will be evaluated. For latissimus dorsi, activation will be measured in six segments separated according to anatomic dissection.

Reach activity will be performed 3 times on each side and at 1 minute intervals.

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sıhhiye/ANKARA
      • Ankara, Sıhhiye/ANKARA, Turkey
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hacettepe University Neurological Rehabilitation Unit

Description

Inclusion Criteria:

  • diagnosed with stroke by a neurologist
  • least 6 mounts after stroke
  • Fugl Meyer Upper Extremity Motor Rating Scale with a value of 40 and above,
  • independent sitting,
  • Mini Mental Status Scale (MMSE)> 24,
  • 30-67 age.

Exclusion Criteria:

  • neurodegenerative disease other than stroke
  • presence of neglect
  • presence of apraxia
  • uncorrected visual impairment
  • neuromusculoskeletal pathologies
  • neck and shoulder pain lasting more than 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stroke patients
An 8-channel surface EMG system (Noraxon Telemyo DTS system, Scottsdale, USA) will be used to measure signals from muscles during surface electromyography measurements.
Healthy Subjects
An 8-channel surface EMG system (Noraxon Telemyo DTS system, Scottsdale, USA) will be used to measure signals from muscles during surface electromyography measurements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface electromyographic measurement
Time Frame: 90 minutes

Muscle activation measurement

It is an 8-channel system for measuring signals come from muscles (Noraxon Telemyo DTS system, Scottsdale, USA).

90 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tuba KAYA, R.A., Hacettepe University
  • Study Director: Sevil BİLGİN, Assoc. Prof., Hacettepe University
  • Study Chair: Muhammed KILINÇ, Assoc. Prof., Hacettepe University
  • Study Chair: Esra DÜLGER, R.A., Hacettepe University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2019

Primary Completion (ACTUAL)

August 7, 2019

Study Completion (ACTUAL)

December 29, 2020

Study Registration Dates

First Submitted

November 25, 2019

First Submitted That Met QC Criteria

November 27, 2019

First Posted (ACTUAL)

November 29, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 20, 2022

Last Update Submitted That Met QC Criteria

April 13, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Electromyographic device

Subscribe